These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27941529)

  • 1. CHANGE OF CHOROIDAL VOLUME IN UNTREATED CENTRAL SEROUS CHORIORETINOPATHY.
    Pertl L; Haas A; Hausberger S; Pichler T; Rabensteiner DF; Seidel G; Malle EM; Weger M
    Retina; 2017 Sep; 37(9):1792-1796. PubMed ID: 27941529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of subretinal fluid volume with choroidal thickness and macular volume in acute central serous chorioretinopathy.
    Goktas A
    Eye (Lond); 2014 Dec; 28(12):1431-6. PubMed ID: 25233823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal choroidal flow on optical coherence tomography angiography in central serous chorioretinopathy.
    Seo EJ; Um T; Yoon YH
    Clin Exp Ophthalmol; 2019 May; 47(4):505-512. PubMed ID: 30515936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Ojima A; Ogasawara M; Spaide RF
    Ophthalmology; 2010 Sep; 117(9):1792-9. PubMed ID: 20472289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.
    Jirarattanasopa P; Ooto S; Tsujikawa A; Yamashiro K; Hangai M; Hirata M; Matsumoto A; Yoshimura N
    Ophthalmology; 2012 Aug; 119(8):1666-78. PubMed ID: 22521082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between morphological characteristics in spectral-domain-optical coherence tomography, different functional tests and a patient's subjective handicap in acute central serous chorioretinopathy.
    Gerendas BS; Kroisamer JS; Buehl W; Rezar-Dreindl SM; Eibenberger KM; Pablik E; Schmidt-Erfurth U; Sacu S
    Acta Ophthalmol; 2018 Nov; 96(7):e776-e782. PubMed ID: 29338130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choroidal Thickness Changes After Photodynamic Therapy and Recurrence of Chronic Central Serous Chorioretinopathy.
    Kim YK; Ryoo NK; Woo SJ; Park KH
    Am J Ophthalmol; 2015 Jul; 160(1):72-84.e1. PubMed ID: 25887629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Ojima A; Sekiryu T
    Retina; 2011 Sep; 31(8):1603-8. PubMed ID: 21487334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.
    van Dijk EHC; Dijkman G; Boon CJF
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):2029-2035. PubMed ID: 28674835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year follow-up of choroidal neovascularisation in eyes of chronic central serous chorioretinopathy.
    Chen YC; Chen SN
    Br J Ophthalmol; 2020 Nov; 104(11):1561-1566. PubMed ID: 32051140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHOROIDAL VASCULARITY INDEX IN CENTRAL SEROUS CHORIORETINOPATHY.
    Agrawal R; Chhablani J; Tan KA; Shah S; Sarvaiya C; Banker A
    Retina; 2016 Sep; 36(9):1646-51. PubMed ID: 27124882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathophysiology of macular diseases--morphology and function].
    Iida T
    Nippon Ganka Gakkai Zasshi; 2011 Mar; 115(3):238-74; discussion 275. PubMed ID: 21476310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional configuration of subretinal fluid in central serous chorioretinopathy.
    Ahn SE; Oh J; Oh JH; Oh IK; Kim SW; Huh K
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):5944-52. PubMed ID: 23920371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical density ratio in the subretinal fluid: differentiating chronic central serous chorioretinopathy and polypodial choroidal vasculopathy.
    Baek J; Park YH
    Am J Ophthalmol; 2015 Feb; 159(2):386-92. PubMed ID: 25447112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHOROIDAL THICKNESS IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY: Assessment of Haller and Sattler Layers.
    Chung YR; Kim JW; Kim SW; Lee K
    Retina; 2016 Sep; 36(9):1652-7. PubMed ID: 26934451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes of choroidal thickness in central serous chorioretinopathy].
    Yang LH; Tian B; Shi XH; Ding N; Zhou D; Wei WB
    Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):874-7. PubMed ID: 23302239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Acetazolamide on Choroidal Morphology in Central Serous Chorioretinopathy.
    Kwak JH; Hong SW; Ra H; Kim EC; Kang NY; Baek J
    Korean J Ophthalmol; 2019 Dec; 33(6):493-499. PubMed ID: 31833245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choroidal thickness and choroidal blood flow after intravitreal bevacizumab injection in eyes with central serous chorioretinopathy.
    Okamoto M; Matsuura T; Ogata N
    Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):25-32. PubMed ID: 25559505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective study.
    Schwartz R; Habot-Wilner Z; Martinez MR; Nutman A; Goldenberg D; Cohen S; Shulman S; Guzner-Gur H; Loewenstein A; Goldstein M
    Acta Ophthalmol; 2017 Nov; 95(7):e610-e618. PubMed ID: 28653813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial.
    Bae SH; Heo J; Kim C; Kim TW; Shin JY; Lee JY; Song SJ; Park TK; Moon SW; Chung H
    Ophthalmology; 2014 Feb; 121(2):558-65. PubMed ID: 24268858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.